+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Expression and prognostic relevance of cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma



Expression and prognostic relevance of cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma



Diagnostic Pathology 8: 207



To guide clinicians in selecting treatment options for esophageal squamous cell carcinoma (ESCC) patients, reliable markers predictive of clinical outcome are desirable. This study analyzed the correlation of cyclophilin A (CypA) and matrix metalloproteinase 9 (MMP9) in ESCC and their relationships to clinicopathological features and survival. We immunohistochemically investigated 70 specimens of ESCC tissues using CypA and MMP9 antibodies. Then, the correlations between CypA and MMP9 expression and clinicopathological features and its prognostic relevance were determined. Significant correlations were only found in high level of CypA and MMP9 expression with tumor differentiation and lymph node status. Significant positive correlations were found between the expression status of CypA and that of MMP9. Overexpression of CypA and metastasis were significantly associated with shorter progression free survival times in univariate analysis. Multivariate analysis confirmed that CypA expression was an independent prognostic factor. CypA might be correlated with the differentiation, and its elevated expression may be an adverse prognostic indicator for the patients of ESCC. CypA/MMP9 signal pathway may be attributed to the malignant transformation of ESCC, and attention should be paid to a possible target for therapy. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1166551968105508.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053147570

Download citation: RISBibTeXText

PMID: 24351116

DOI: 10.1186/1746-1596-8-207


Related references

CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 101(9): 1994-2000, 2004

Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention 17(6): 2781-2785, 2017

Potential prognostic importance of the expression of matrix metalloproteinase MMP9 and tissue inhibitor of metalloproteinase TIMP2 in patients with laryngeal squamous cell carcinoma. 2007

Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World Journal of Gastroenterology 11(6): 871-874, 2005

Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma. International Journal of Experimental Pathology 96(5): 311-318, 2016

Expression and prognostic relevance of Id1 in stage III esophageal squamous cell carcinoma. Cancer Biomarkers 8(2): 67-72, 2011

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. Bmc Cancer 10: 467, 2011

Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis. Journal of Clinical and Experimental Dentistry 8(2): E130-E135, 2016

Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma. World Journal of Gastroenterology 16(41): 5195-5202, 2011

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Annals of Thoracic Surgery 93(5): 1682-1688, 2012

Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma. Diseases of the Esophagus 25(1): 67-71, 2012

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. International Journal of Cancer 110(2): 201-207, 2004

Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88(10): 2201-2209, May 15, 2000

The expression and clinical significance of metastasis suppressor gene and matrix metalloproteinase-2 in esophageal squamous cell of carcinoma. Pakistan Journal of Pharmaceutical Sciences 29(4 Suppl): 1339-1342, 2017

Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells. Molecular Cancer Research 10(5): 588-596, 2012